FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Report: Trump Sending In the Great Tom Homan to Personally Take Command in Minneapolis and Reassigning Bovino After Shooting

Sewage spill sends E coli surging in the Potomac River near DC

Feds charge 87 individuals in massive ATM ‘jackpotting’ operation linked to Tren de Aragua gang

Mamdani’s early moves as mayor clash with affordability pledge: ‘Ripple effects are significant’

Trump admin wins court victory freeing ICE agents from Minnesota protest restrictions

DOJ could soon ask Supreme Court to consider legal battle over Trump-appointed US attorneys

Trump has ‘very good’ call with Minneapolis Mayor Frey, announces border czar Homan meeting

ALERT: US Holocaust Museum Responds After Tim Walz Invokes Anne Frank’s Name, Calls Exploiting Holocaust ‘Deeply Offensive’

GOP senator demands DHS immigration chiefs testify after fatal shootings in Minnesota

Conservative Party defections to Reform UK continue with former home secretary

Democrats lay out immigration demands as Congress careens toward shutdown

Chicago teacher placed on leave after Facebook post supporting ICE sparks outrage from activists

Report: Iran’s Supreme Leader Khamenei Now Living in Underground Bunker, Fears Trump Might Come for Him

‘This Is Not a Protest’: Former Special Ops Soldier Says Insurgent Tactics Being Used in Minnesota

Border Patrol Commander Gregory Bovino to leave Minnesota, as Tom Homan takes over

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”